Phenylephrine promotes phosphorylation of bad in cardiac myocytes through the extracellular signal-regulated kinases 1/2 and protein kinase A

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 7, 2002, Pages 749-763

  Valks, Donna M ^a   Cook, Stuart A ^b   Pham, Fong H ^a   Morrison, Paul R ^b   Clerk, Angela ^a   Sugden, Peter H ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Adrenoceptors; Apoptosis; Bcl 2 proteins; cAMP; Cardiac myocytes; Mitogen activated protein kinases

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ALPHA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; DEOXYGLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; PROTEIN BAD;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CATALYSIS; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PURIFICATION; ENZYME REGULATION; FAST PROTEIN LIQUID CHROMATOGRAPHY; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

EID: 0036660617     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2014     Document Type: Article

References (66)

1. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J 1991; 5: 3037-3046.
2. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998: 76: 725-746.
3. Bogoyevitch MA, Glennon PE, Andersson MB, Clerk A, Lazou A, Marshall CJ, Parker PJ, Sugden PH. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994: 269: 1110-1119.
4. Clerk A, Bogoyevitch MA, Andersson MB, Sugden PH. Differential activation of protein kinase C isoforms by endothelin-1 and phenylephrine, and subsequent stimulation of p42 and p44 mitogen-activated protein kinases in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 1994; 269: 32 848-32 857.
5. Bogoyevitch MA, Ketterman AJ, Sugden PH. Cellular stresses activate c-Jun N-terminal protein kinases (JNKs) in ventricular myocytes cultured from neonatal rat hearts. J Biol Chem 1995; 270: 29 710-29 717.
6. Clerk A, Michael A, Sugden PH. Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy? J Cell Biol 1998: 142: 523-535.
7. Nicol RL, Frey N, Pearson G, Cobb M, Richardson J, Olson EN. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J 2001; 20: 2757-2767.
8. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993; 73: 381-393.
9. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Gen Dev 1994; 4: 96-101.
10. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988; 334: 715-718.
11. Frödin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol Cell Endocrinol 1999; 151: 65-77.
12. Liang Q, Wiese RJ, Bueno OF, Dai YS, Markham BE, Molkentin JD. The transcription factor GATA4 is activated by extracellular signal-regulated kinase 1- and 2-mediated phosphorylation of serine 105 in cardiomyocytes. Mol Cell Biol 2001; 21: 7460-7469.
13. Molkentin JD. The zinc finger-containing transcription factors GATA-4, -5, and -6. Ubiquitously expressed regulators of tissue-specific gene expression. J Biol Chem 2000; 275: 38 949-38 952.
14. Molkentin JD, Lu J-R, Antos C, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-228.
15. De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW II, Kitsis RN, Molkentin JD. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res 2000; 86: 255-263.
16. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000; 86: 692-699.
17. Wang Y, Huang S, Sah VP, Ross J, Brown JH, Han J, Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998; 273: 2161-2168.
18. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999: 99: 1685-1691.
19. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 2001; 88: 305-312.
20. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-1911.
21. Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69: 217-245.
22. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2905-2927.
23. Vanhaesebroeck B, Alessi DR. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 2000; 346: 561-576.
24. Datta SR, Katsov A, Hu L, Petros A, Fesik A, Yaffe MB, Greenberg ME. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 2000; 6: 41-51.
25. Lizcano JM, Morrice N, Cohen P. Regulation of BAD by caMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J 2000; 349: 547-557.
26. Tan Y, Demeter MR, Ruan H, Comb MJ. BAD Ser-155 phosphorylation regulates J BAD:Bcl-XL interaction and cell survival. J Biol Chem 2000; 275: 25 865-25 869.
27. Virdee K, Parone PA, Tolkovsky AM. Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival. Curr Biol 2000; 10: 1151-1154.
28. Zhou X-M, Liu Y, Payne G, Lutz RJ, Chittenden T. Growth factors inactivate the cell death promoter. BAD, by phosphorylation of its BH3 domain on serine 155. J Biol Chem 2000; 275: 25 046-25 051.
29. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R, Duronio V. Identification of a novel phosphorylation site. Ser170, as a regulator of Bad pro-apoptotic activity. J Biol Chem 2002: 277: 6399-6405.
30. 1. Cell 1996; 87: 619-628.
31. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231-241.
32. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science 1997; 278: 687-689.
33. Harada H, Andersen JS, Mann M, Terada N, Korsmeyer SJ. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc Natl Acad Sci USA 2001; 98: 9666-9670.
34. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358-1362.
35. Bertolotto C, Maulon L, Filippa N, Baier G, Auberger P. Protein kinase Cθ and ε promote T-cell survival by a Rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem 2000; 275: 37 246-37 250.
36. Shimamura A, Ballif BA, Richards SA, Blenis J. Rsk1 mediates a MEK-MAP kinase survival signal. Curr Biol 2000; 10: 127-135.
37. RSK blocks Bad-mediated cell death via a protein kinase C-dependent pathway. J Biol Chem 1999; 274: 34 859-34 867.
38. Bogoyevitch MA, Andersson MB, Gillespie-Brown J, Clerk A, Glennon PE, Fuller SJ, Sugden PH. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J 1996; 314: 115-121.
39. 1-mediated response. J Biol Chem 1990; 265: 13 809-13 817.
40. Cook SA, Sugden PH, Clerk A. Regulation of Bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 1999; 85: 940-949.
41. Chiloeches A, Paterson HF, Marais RM, Clerk A, Marshall CJ, Sugden PH. Regulation of Ras.GTP loading and Ras-Raf association in neonatal rat ventricular myocytes by G protein-coupled receptor agonists and phorbol esters. Activation of the ERK cascade by phorbol esters is mediated by Ras. J Biol Chem 1999; 274: 19 762-19 770.
42. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama S. α- and β-Adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 1999; 100: 305-311.
43. Zhu H, McElwee-Witmer S, Perrone M, Clark KL, Zilberstein A. Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ 2001: 7: 773-784.
44. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000: 351: 95-105.
45. Pham FH, Cole SM, Clerk A. Regulation of cardiac myocyte protein synthesis through phosphatidylinositol 3′ kinase and protein kinase B. Adv Enzyme Regul 2001; 41: 73-86.
46. Alessi DR. The protein kinase C inhibitor Ro 318220 and GF 109203X are equally potent inhibitors of MAPKAPK kinase-1β (Rsk-2) and p70 S6 kinase. FEBS Lett 1997: 402: 121-123.
47. Pham FH, Sugden PH, Clerk A. Regulation of protein kinase B and 4E-BP1 by oxidative stress in cardiac myocytes. Circ Res 2000; 86: 1252-1258.
48. Kamakura S, Moriguchi T, Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J Biol Chem 1999; 274: 26 563-26 571.
49. Mody N, Leitch J, Armstrong C, Dixon J, Cohen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett 2001: 502: 21-24.
50. Haunstetter A, Izumo S. Towards antiapoptosis as a new treatment modality. Circ Res 2000; 86: 371-376.
51. Kang PM, Izumo S. Apoptosis and heart failure: a critical review of the literature. Circ Res 2000; 86: 1107-1113.
52. Oh H, Fujio Y, Kunisada K, Hirota H, Matsui H, Kishimoto T, Yamauchi-Takihara K. Activation of phosphatidylinositol 3-kinase through glycoprotein 130 induces protein kinase B and p70 S6 kinase phosphorylation in cardiac myocytes. J Biol Chem 1998; 273: 9703-9710.
53. Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Nakao K. Cardiotrophin-1 phosphorylates akt and BAD. and prolongs cell survival via a P13K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol 2000: 32: 1385-1394.
54. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K, Kishimoto T, Yamauchi-Takihara K. Glyocoprotein 130 regulates cardiac myocyte survival in doxirubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase 3 interaction. Circulation 2000; 103: 555-561.
55. Wu W, Lee WL, Wu YY, Chen D, Liu TJ, Jang A, Sharma PM, Wang PH. Expression of constitutively active phosphatidylinositol 3-kinase inhibits activation of caspase 3 and apoptosis in cardiac muscle cells. J Biol Chem 2000; 275: 40113-40119.
56. 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res 1997; 81: 176-186.
57. Schlüter KD, Simm A, Schafer M, Taimor G, Piper HM. Early response kinase and PI 3-kinase activation in adult cardiomyocytes and their role in hypertrophy. Am J Physiol 1999; 276: H1655-H1663.
58. Hamnér S, Arumäe U, Li-Ying Y, Sun Y-F, Saarma M, Lindholm D. Functional characterization of two splice variants of rat Bad and their interaction with Bcl-w in sympathetic neurons. Mol Cell Neurosci 2001; 17: 97-106.
59. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, Kikkawa R, Cantley LC. Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem 2000: 275: 36 108-36 115.
60. Leighton IA, Dalby KN, Caudwell FB, Cohen PT, Cohen P. Comparison of the specificities of p70 S6 kinase and MAPKAP kinase-1 identifies a relatively specific substrate for p70 S6 kinase: the N-terminal kinase domain of MAPKAP kinase-1 is essential for peptide phosphorylation. FEBS Lett 1995; 375: 289-293.
61. Songyang Z, Blechner S, Hoagland N, Hoekstra MF. Piwnica-Worms H, Cantley LC. Use of an orientated peptide library to determine the optimal substrates of protein kinases. Curr Biol 1994; 4: 973-982.
62. Hasegawa K, Iwai-Kanai E, Sasayama S. Neurohormonal regulation of myocardial cell apoptosis during the development of heart failure. J Cell Physiol 2001: 186: 11-18.
63. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS. Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 2001; 189: 257-265.
64. Henaff M, Hatem SN, Mercadier JJ. Low catecholamine concentrations protect adult rat ventricular myocytes against apoptosis through cAMP-dependent extracellular signal-regulated kinase activation. Mol Pharmacol 2000; 58: 1546-1553.
65. Sugden PH. Signalling pathways in cardiac myocyte hypertrophy. Ann Med 2001: 33: 611-622.
66. Yang E, Zha J, Jockel J, Boise LH, Thomson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.